Skip to main content Back to Top

What You Need to Know About Obesity and Newer Treatments – Part 1

February 23, 2024


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Join expert faculty as they discuss part one of what you need to know about obesity and newer treatment options. This episode touches on lifestyle modifications, chronicity of obesity medications, adverse effects and drug interactions, cost and access of these medications, and more!


Jennifer N. Clements Jennifer N. Clements, PharmD, BCPS, BCACP, BC-ADM, CDCES, FCCP, FADCES is a Clinical Professor and Director of Pharmacy Education with the University of South Carolina College of Pharmacy at the School of Medicine – Greenville Campus. Dr. Clements earned her Pharm.D. from Campbell University in 2006 and completed a primary care pharmacy practice residency in 2007 at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. She is a board-certified pharmacotherapy specialist, board-certified ambulatory care pharmacist, certified diabetes care and education specialist, and board certified in advanced diabetes management. Dr. Clements She has authored numerous publications and presentations related to diabetes and obesity pharmacotherapy. 

Diana IsaacsDiana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an endocrine clinical pharmacy specialist and the director of Education and Training in Diabetes Technology at the Cleveland Clinic. Dr. Isaacs serves in leadership roles for several pharmacy and diabetes organizations. She served on the ADA Professional Practice Committee for 2020-2023, the committee that updates the ADA Standards of Care. She is a national board member of the Association of Diabetes Care and Education Specialists. Dr. Isaacs was awarded the Ohio Pharmacists Association Under 40 Award in 2019 and was the 2020 ADCES Diabetes Care and Education Specialist of the Year. In 2022, she was inducted into the Southern Illinois University Edwardsville Hall of Fame for her far-reaching contributions in patient care. 

Relevant Financial Relationship Disclosures

The following persons in control of this activity’s content have relevant financial relationships:

  • Jennifer N. Clements: Novo Nordisk – Speaker’s bureau; Xeris Pharmaceuticals – Consultant; Embecta – Advisory board; Lilly – Speaker’s bureau 
  • Diana Isaacs: Dexcom – Speaker’s bureau; Abbott – Speaker’s bureau; Novo Nordisk – Speaker’s bureau; Lilly - Speaker’s bureau; Sanofi – Consultant 

All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.  


More in This Series


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.  
Provided by ASHP and Supported by an educational grant from Novo Nordisk Inc.